New real-world evidence highlights lebrikizumab’s effectiveness and safety in atopic dermatitis. Discover how patients ...

For Tracy Owen, eczema was much more than dry skin. It came to dictate every aspect of her life, from ­relationships to how she dressed.

Announced new data demonstrating a unique mechanism of action supporting the best-in-class potential of rademikibart –– Recruitment ongoing for ...

The patent for Dupixent, called the "miracle atopic dermatitis treatment," will expire around 2031. Dupixent was co-developed by French drugmaker Sanofi and U.S. biotech Regeneron and posted $14.1 ...